We are live on ! Find out more
WVE icon

Wave Life Sciences
WVE

91 hedge funds and large institutions have $306M invested in Wave Life Sciences in 2020 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 28 increasing their positions, 24 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 9

42% more call options, than puts

Call options by funds: $1.71M | Put options by funds: $1.21M

17% more funds holding

Funds holding: 78 → 91 (+13)

17% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 24

9% more capital invested

Capital invested by funds: $282M → $306M (+$24.2M)

4.8% less ownership

Funds ownership: 87.15% → 82.35% (-4.8%)

Holders
91
Holders Change
+13
Holders Change %
+16.67%
% of All Funds
1.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
28
Reduced
24
Closed
9
Calls
$1.71M
Puts
$1.21M
Net Calls
+$504K
Net Calls Change
-$1.42M

Top Buyers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
+$7.28M
2
GTC
Ghost Tree Capital
New York
+$5.03M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$4.99M
4
BlackRock
BlackRock
New York
+$4.6M
5
Morgan Stanley
Morgan Stanley
New York
+$4.36M

Top Sellers

Rank Fund Capital Flow
1
RG
Redmile Group
California
-$23.6M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$18.6M
3
RI
RTW Investments
New York
-$9.4M
4
SIM
Spark Investment Management
New York
-$754K
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$622K
Name Holding Trade Value Shares
Change 		Change in
Stake
PIM
26
Platinum Investment Management
Australia
$1.31M – – –
Millennium Management
27
Millennium Management
New York
$1.28M +$1.16M +123,387 New
SC
28
Sculptor Capital
New York
$1.25M – – –
Charles Schwab
29
Charles Schwab
California
$1.2M -$58.6K -6,226 -5%
ACP
30
Acuta Capital Partners
California
$1.12M +$1.01M +107,500 New
N
31
Nuveen
North Carolina
$1.09M -$50.8K -5,394 -5%
Goldman Sachs
32
Goldman Sachs
New York
$1.05M +$372K +39,496 +64%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$857K -$44.9K -4,774 -5%
Bessemer Group
34
Bessemer Group
New Jersey
$816K +$738K +78,400 New
SSA
35
Schonfeld Strategic Advisors
New York
$750K +$678K +72,100 New
Axa
36
Axa
France
$701K +$633K +67,300 New
Russell Investments Group
37
Russell Investments Group
United Kingdom
$700K +$226K +24,055 +56%
PP
38
PDT Partners
New York
$623K -$548K -58,239 -49%
SFI
39
Susquehanna Fundamental Investments
Pennsylvania
$545K +$493K +52,364 New
AllianceBernstein
40
AllianceBernstein
Tennessee
$499K +$94.1K +10,000 +26%
ECM
41
ExodusPoint Capital Management
New York
$487K +$440K +46,763 New
Swiss National Bank
42
Swiss National Bank
Switzerland
$478K +$92.2K +9,800 +27%
WM
43
WS Management
Florida
$467K -$74K -7,866 -15%
MC
44
Matisse Capital
Oregon
$459K -$253K -26,917 -38%
Deutsche Bank
45
Deutsche Bank
Germany
$453K -$69.2K -7,354 -14%
PPA
46
Parametric Portfolio Associates
Washington
$442K +$297K +31,601 +292%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$433K -$25.4K -2,700 -6%
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$433K +$28.2K +3,000 +8%
Voloridge Investment Management
49
Voloridge Investment Management
Florida
$396K -$93.6K -9,949 -21%
Barclays
50
Barclays
United Kingdom
$394K +$47.9K +5,091 +16%
1
2
3 4

WVE Hedge Fund Activity: Q2 2020 in Review

91 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q2 2020, worth a combined $306M — up 8.6% from $282M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new WVE positions and 9 closed out — a net gain of 13 holders — while 28 added to existing stakes and 24 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $7.28M. The largest seller was Redmile Group, cutting an estimated $23.6M.

  • 91 institutional investors held Wave Life Sciences (WVE) as of Q2 2020, up from 78 in Q1 2020.
  • Funds reported $306M of Wave Life Sciences stock for Q2 2020, up 8.6% quarter-over-quarter.
  • 22 funds opened new Wave Life Sciences positions in Q2 2020 and 9 closed out, a net change of +13 holders.
  • The largest Wave Life Sciences buyer in Q2 2020 was Nantahala Capital Management, an estimated $7.28M added.
  • The largest Wave Life Sciences seller in Q2 2020 was Redmile Group, an estimated $23.6M sold.

Based on aggregated 13F filings for Q2 2020.